1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Be, X.
Hong, Y.
Androphy, E.J.
Chen, J.J.
Baleja, J.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
40
1293
1299
10.1021/bi0019592
11170455
Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP.
2001
10.2210/pdb1eqx/pdb
pdb_00001eqx
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2101.316
PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN
6.3.2.-
E6-INTERACTING PEPTIDE
1
nat
polymer
no
no
IPESSELTLQELLGEERR
IPESSELTLQELLGEERR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-02-28
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
RCSB
Y
RCSB
2000-04-06
REL
REL
This structure was determined using standard 2D homonuclear techniques
structures with acceptable covalent geometry, structures with the least restraint violations
30
24
2D NOESY
10 mM Na3PO4
6.2
ambient
288
K
simulated annealing
24
closest to the average, fewest violations
2 mM E6ap; 10 mM phosphate buffer; 40% TFE, 60% H2O
40% TFE, 60% H2O
BRUNGER
structure solution
X-PLOR
3.81
BRUNGER
refinement
X-PLOR
3.81
500
Bruker
AMX
ILE
1
n
1
ILE
1
A
PRO
2
n
2
PRO
2
A
GLU
3
n
3
GLU
3
A
SER
4
n
4
SER
4
A
SER
5
n
5
SER
5
A
GLU
6
n
6
GLU
6
A
LEU
7
n
7
LEU
7
A
THR
8
n
8
THR
8
A
LEU
9
n
9
LEU
9
A
GLN
10
n
10
GLN
10
A
GLU
11
n
11
GLU
11
A
LEU
12
n
12
LEU
12
A
LEU
13
n
13
LEU
13
A
GLY
14
n
14
GLY
14
A
GLU
15
n
15
GLU
15
A
GLU
16
n
16
GLU
16
A
ARG
17
n
17
ARG
17
A
ARG
18
n
18
ARG
18
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
OE1
HH21
GLU
ARG
16
17
1.60
3
A
A
OE1
HE
GLU
ARG
15
18
1.54
4
A
A
HB2
HB2
GLU
LEU
3
7
1.28
5
A
A
OE2
HH21
GLU
ARG
15
18
1.60
7
A
A
OE1
HH11
GLU
ARG
15
18
1.59
7
A
A
OE2
HH12
GLU
ARG
16
17
1.59
8
A
A
OE2
HH11
GLU
ARG
15
18
1.59
9
A
A
OE1
HH12
GLU
ARG
16
17
1.50
9
A
A
OE2
HH12
GLU
ARG
15
18
1.54
10
A
A
OE1
HE
GLU
ARG
15
18
1.54
10
A
A
OE1
HH22
GLU
ARG
16
17
1.54
12
A
A
OE2
HH11
GLU
ARG
15
18
1.55
13
A
A
OE1
HH12
GLU
ARG
15
18
1.52
13
A
A
H3
OE2
ILE
GLU
1
3
1.53
13
A
A
O
HG1
SER
THR
5
8
1.58
14
A
A
OE2
HH21
GLU
ARG
16
17
1.59
15
A
A
H2
OE1
ILE
GLU
1
3
1.53
16
A
A
OE2
HH21
GLU
ARG
15
18
1.51
17
A
A
OE1
HH22
GLU
ARG
11
18
1.53
17
A
A
OE1
HH21
GLU
ARG
15
18
1.54
17
A
A
H2
OE2
ILE
GLU
1
3
1.56
18
A
A
OE1
HE
GLU
ARG
16
17
1.55
18
A
A
OE2
HH21
GLU
ARG
16
17
1.58
19
A
A
O
HG1
SER
THR
4
8
1.59
20
A
A
OE1
HH21
GLU
ARG
15
18
1.55
21
A
A
OE1
HE
GLU
ARG
15
18
1.53
23
A
A
HH12
OXT
ARG
ARG
17
18
1.59
24
A
A
OE1
HH21
GLU
ARG
15
18
1.56
1
A
PRO
2
-78.68
44.73
1
A
SER
4
69.40
-39.16
1
A
LEU
13
-78.51
32.04
1
A
ARG
17
-106.88
40.71
2
A
LEU
13
-87.03
37.43
3
A
GLU
3
-69.91
55.37
3
A
SER
4
-168.63
-54.81
3
A
LEU
13
-87.94
42.45
3
A
ARG
17
-107.03
70.57
4
A
SER
4
54.39
-89.82
4
A
LEU
13
-84.62
42.71
5
A
GLU
3
-72.12
49.74
6
A
LEU
13
-85.97
39.30
7
A
SER
4
-75.23
39.04
7
A
LEU
13
-91.30
46.08
7
A
ARG
17
-85.65
48.92
8
A
GLU
3
-56.78
92.24
8
A
SER
4
-160.30
-52.50
8
A
LEU
13
-89.15
41.76
8
A
ARG
17
-99.23
57.76
9
A
SER
4
-172.25
-52.94
9
A
LEU
13
-97.83
48.33
10
A
ARG
17
-110.86
59.47
11
A
PRO
2
-70.23
44.00
12
A
GLU
3
-75.22
49.01
13
A
PRO
2
-68.47
51.87
13
A
LEU
13
-90.44
41.95
15
A
PRO
2
-66.82
53.36
15
A
ARG
17
-101.26
52.24
16
A
SER
4
-160.85
-42.01
16
A
LEU
13
-86.39
40.03
16
A
ARG
17
-145.34
28.93
17
A
LEU
13
-83.72
45.85
17
A
GLU
16
-85.65
41.27
17
A
ARG
17
-152.21
-47.35
18
A
LEU
13
-87.97
42.14
18
A
ARG
17
-108.37
44.17
19
A
SER
4
-155.60
-61.31
19
A
ARG
17
-78.28
41.91
20
A
LEU
13
-86.13
38.44
21
A
LEU
13
-96.52
46.37
21
A
ARG
17
-142.17
26.90
22
A
SER
4
52.58
-86.99
22
A
LEU
13
-94.62
42.21
23
A
PRO
2
-68.77
54.29
24
A
PRO
2
-16.46
76.56
24
A
LEU
13
-84.05
41.36
24
A
ARG
17
-84.22
44.94
SOLUTION STRUCTURE DETERMINATION AND MUTATIONAL ANALYSIS OF THE PAPILLOMAVIRUS E6-INTERACTING PEPTIDE OF E6AP
1
N
N
A
SER
4
A
SER
4
HELX_P
A
GLU
16
A
GLU
16
1
1
13
LIGASE
alpha helix, LIGASE
UBE3A_HUMAN
UNP
1
Q05086
401
418
1EQX
1
18
Q05086
A
1
1
18
1
P 1